Varex Imaging (NASDAQ:VREX) Rating Lowered to Hold at Zacks Research

Varex Imaging (NASDAQ:VREXGet Free Report) was downgraded by equities research analysts at Zacks Research from a “strong-buy” rating to a “hold” rating in a research note issued to investors on Monday,Zacks.com reports.

Other research analysts also recently issued reports about the company. Wall Street Zen raised Varex Imaging from a “hold” rating to a “buy” rating in a report on Saturday, July 4th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Varex Imaging in a research report on Wednesday, June 24th. Two analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Varex Imaging presently has a consensus rating of “Hold” and an average price target of $16.17.

Check Out Our Latest Stock Analysis on Varex Imaging

Varex Imaging Trading Up 1.4%

Shares of VREX stock opened at $11.13 on Monday. Varex Imaging has a 12-month low of $6.76 and a 12-month high of $14.56. The company has a market capitalization of $468.57 million, a P/E ratio of -5.57 and a beta of 0.90. The firm has a 50-day moving average price of $10.51 and a 200 day moving average price of $11.61. The company has a quick ratio of 1.43, a current ratio of 3.20 and a debt-to-equity ratio of 0.67.

Varex Imaging (NASDAQ:VREXGet Free Report) last issued its quarterly earnings data on Thursday, May 7th. The company reported $0.21 earnings per share for the quarter, missing the consensus estimate of $0.22 by ($0.01). The firm had revenue of $216.00 million for the quarter, compared to the consensus estimate of $216.92 million. Varex Imaging had a positive return on equity of 8.19% and a negative net margin of 9.64%.Varex Imaging has set its Q3 2026 guidance at 0.150-0.300 EPS. Research analysts forecast that Varex Imaging will post 0.93 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the business. Rockefeller Capital Management L.P. acquired a new position in Varex Imaging during the 4th quarter valued at about $27,000. Quarry LP bought a new stake in shares of Varex Imaging during the third quarter worth approximately $64,000. BNP Paribas Financial Markets raised its stake in shares of Varex Imaging by 18.5% during the second quarter. BNP Paribas Financial Markets now owns 13,045 shares of the company’s stock worth $113,000 after buying an additional 2,036 shares during the last quarter. Aquatic Capital Management LLC acquired a new position in Varex Imaging in the third quarter valued at approximately $117,000. Finally, Cerity Partners LLC bought a new position in Varex Imaging in the second quarter valued at approximately $123,000.

About Varex Imaging

(Get Free Report)

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.

See Also

Analyst Recommendations for Varex Imaging (NASDAQ:VREX)

Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with MarketBeat.com's FREE daily email newsletter.